Specs
Delftechpark 30,
2628 XH Delft
Netherlands
Tel: +31 15 2518111
Fax: +31 15 2518181
Email Us |
|
Specs is one of the world leading suppliers of screening compounds for lead discovery programs. A world wide network of more than 20,000 academic researchers enables Specs to provide real chemical diversity on the basis of single synthesized, well characterized and druglike small molecules. Furthermore, Specs offers Building Blocks for synthesis and isolated Natural Products. The current stock of 175,000 compounds is (sub)structure searchable through SPECSnet with on-line availability information and ordering. Visit our web site for more information.
Further Information: http://www.specs.net/
Related news from our archive
Thrombotargets and Specs Achieve Milestone in Drug Discovery Collaboration and Begin a new Anticoagulant Program
Thrombotargets and Specs will continue drug discovery collaboration to take advantage of their technologies in the Hit to Lead process.
Thrombotargets and Specs Achieve Milestone in Drug Discovery Collaboration and Begin a new Anticoagulant Program
Thrombotargets and Specs will continue drug discovery collaboration to take advantage of their technologies in the Hit to Lead process.